I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Real clinical experience after one year of treatment with t..:
Javier Naranjo
;
Francisco Borrego
;
José Luis Rocha
...
https://www.frontiersin.org/articles/10.3389/fmed.2022.987092/full. , 2022
Link:
https://doi.org/10.3389/fmed.2022.987092
RT Journal T1
Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d05ba1f52546485cbf29ba449c183e8a&Exemplar=1&LAN=DE A1 Javier Naranjo A1 Francisco Borrego A1 José Luis Rocha A1 Mercedes Salgueira A1 Maria Adoración Martín-Gomez A1 Cristhian Orellana A1 Ana Morales A1 Fernando Vallejo A1 Pilar Hidalgo A1 Francisca Rodríguez A1 Remedios Garófano A1 Isabel González A1 Rafael Esteban A1 Mario Espinosa PB Frontiers Media S.A. YR 2022 K1 glomerular filtration rate (eGFR) K1 hepatic toxicity K1 polycystic kidney disease (PKD) K1 tolvaptan K1 urinary osmolality K1 Medicine (General) K1 R5-920 JF https://www.frontiersin.org/articles/10.3389/fmed.2022.987092/full LK http://dx.doi.org/https://doi.org/10.3389/fmed.2022.987092 DO https://doi.org/10.3389/fmed.2022.987092 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)